arrow
E

Eun Sung Yang

national institutes of health
H指数:34
被引数:8,852

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cross-neutralizing and potent human monoclonal antibodies against historical and emerging H5Nx influenza viruses

针对历史和新兴H5Nx流感病毒的交叉中和强效人单克隆抗体

2025-10-140
OAAI
Pre-exposure antibody prophylaxis protects macaques from severe influenza

暴露前抗体预防可保护猕猴免受严重流感的侵害

Science
IF45.8
2025-01-010
PRE
A multispecific antibody against SARS-CoV-2 prevents immune escape in vitro and confers prophylactic protection in vivo
2024-10-090
PRE
Ultrapotent Broadly Neutralizing Human-llama Bispecific Antibodies against HIV-1

超广谱广谱中和人-美洲驼双特异性HIV-1抗体

2024-05-050
OAAI
Enhancing Anti-SARS-CoV-2 Neutralizing Immunity by Genetic Delivery of Enveloped Virus-like Particles Displaying SARS-CoV-2 Spikes

通过遗传传递显示SARS-CoV-2尖峰的包膜病毒样颗粒来增强Anti-SARS-CoV-2中和免疫力

2023-08-311
OAAI
Self-assembling SARS-CoV-2 spike-HBsAg nanoparticles elicit potent and durable neutralizing antibody responses via genetic delivery
2023-08-084
OAAI
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity
2023-07-2712
OAAI
Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency
MABS
IF7.3
2023-02-028
OAAI
Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones

初次暴露于SARS-CoV-2变体会引起收敛的表位特异性,免疫球蛋白V基因的使用和公共b细胞克隆

2022-12-145
OAAI
Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition
IMMUNITY
IF26.3
2022-11-0115
OAAI
Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half life
2022-10-256
OAAI
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
2022-05-01281
OAAI
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial
2022-02-0397
OAAI
Broadly neutralizing antibodies target the coronavirus fusion peptide
Science
IF45.8
2022-01-010
OA
Potent anti-viral activity of a trispecific HIV neutralizing antibody in SHIV-infected monkeys
2022-01-0118
OA
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern
2021-10-2075
OAAI
Blocking α4β7 integrin delays viral rebound in SHIVSF162P3-infected macaques treated with anti-HIV broadly neutralizing antibodies
2021-08-1810
OA